Björkhem I, Starck L, Andersson U, Lütjohann D, von Bahr S, Pikuleva I, Babiker A, Diczfalusy U
Division of Clinical Chemistry, Huddinge University Hospital, Sweden.
J Lipid Res. 2001 Mar;42(3):366-71.
Infants with the cholesterol synthesis defect Smith- Lemli-Opitz syndrome (SLO) have reduced activity of the enzyme 7-dehydrocholesterol-7-reductase and accumulate 7-dehydrocholesterol, with the highest concentration in the brain. As a result of the generally reduced content of cholesterol, plasma levels of oxysterols would be expected to be reduced. 24S-hydroxycholesterol is almost exclusively formed in the brain, whereas 27-hydroxycholesterol is mainly formed from extrahepatic and extracerebral cholesterol. In accordance with the expectations, sterol-correlated plasma levels of 24S-hydroxycholesterol were reduced in infants with SLO (by about 50%). In contrast, the sterol-correlated levels of 27-hydroxycholesterol in the circulation were markedly increased. No side-chain oxidized metabolites of 7-dehydrocholesterol were detected in the circulation. Recombinant human CYP27 had markedly lower 27-hydroxylase activity toward 7-dehydrocholesterol than towards cholesterol. HEK293 cells expressing 24S-hydroxylase active toward cholesterol had no significant activity towards 7-dehydrocholesterol. The plasma levels of 3 beta,7 alpha-dihydroxy-5-cholestenoic in the patients acid were reduced, suggesting a generally reduced metabolism of 27-oxygenated steroids. It is concluded that the accumulation of 7-dehydrocholesterol in the brains of patients with SLO reduces formation of 24S-hydroxycholesterol. The condition is associated with markedly increased circulating levels of 27-hydroxycholesterol, most probably due to reduced metabolism of this oxysterol. We discuss the possibility that the circulating levels of 24S-hydroxycholesterol may be used as a marker for the severity of the disease.--Björkhem, I., L. Starck, U. Andersson, D. Lütjohann, S. von Bahr, I. Pikuleva, A. Babiker, and U. Diczfaulsy. Oxysterols in the circulation of patients with the Smith-Lemli-Opitz syndrome: abnormal levels of 24S- and 27-hydroxycholesterol. J. Lipid Res. 2001. 42: 366--371.
患有胆固醇合成缺陷的史密斯-利姆利-奥皮茨综合征(SLO)的婴儿,其7-脱氢胆固醇-7-还原酶的活性降低,7-脱氢胆固醇蓄积,在大脑中的浓度最高。由于胆固醇含量普遍降低,预计血浆中氧化甾醇水平也会降低。24S-羟基胆固醇几乎完全在大脑中形成,而27-羟基胆固醇主要由肝外和脑外胆固醇形成。与预期一致,SLO婴儿中与甾醇相关的血浆24S-羟基胆固醇水平降低(约50%)。相反,循环中与甾醇相关的27-羟基胆固醇水平显著升高。在循环中未检测到7-脱氢胆固醇的侧链氧化代谢产物。重组人CYP27对7-脱氢胆固醇的27-羟化酶活性明显低于对胆固醇的活性。表达对胆固醇有活性的24S-羟化酶的HEK293细胞对7-脱氢胆固醇无明显活性。患者血浆中3β,7α-二羟基-5-胆甾烯酸水平降低,提示27-氧化甾醇的代谢普遍降低。结论是,SLO患者大脑中7-脱氢胆固醇的蓄积减少了24S-羟基胆固醇的形成。这种情况与循环中27-羟基胆固醇水平显著升高有关,很可能是由于这种氧化甾醇的代谢降低。我们讨论了循环中24S-羟基胆固醇水平可作为该疾病严重程度标志物的可能性。——比约克姆,I.,L. 斯塔克,U. 安德森,D. 吕特乔汉,S. 冯·巴尔,I. 皮库列娃,A. 巴比克,和U. 迪茨福尔西。史密斯-利姆利-奥皮茨综合征患者循环中的氧化甾醇:24S-和27-羟基胆固醇的异常水平。《脂质研究杂志》。2001年。42: 366 - 371。